Not applicableStudy completedNCT01007227What this trial is testingMetabolic Syndrome and Fingertip Endothelial DysfunctionWho this might be right forMetabolic Syndrome Kumamoto University 70
Not applicableStudy completedNCT04922970What this trial is testingStrength Training as Prevention and Treatment of Late Effects in Long-term Survivors of Pediatric HSCT.Who this might be right forStem Cell TransplantLate EffectMetabolic Syndrome+1 more Rigshospitalet, Denmark 28
Testing effectiveness (Phase 2)Study completedNCT00070694What this trial is testingAn Investigation of the Antidepressant Efficacy of the 5-HT2A Antagonist, M100907, in Combination With Citalopram in Treatment Resistant DepressionWho this might be right forDepressive Disorder National Institute of Mental Health (NIMH) 96
Not applicableStudy completedNCT05840588What this trial is testingEffect of Bifidobacterium Breve PRL2020 (an Amoxicillin-clavulanate-resistant Strain) on Gastrointestinal Symptoms and Gut Microbiota Composition in Children Treated With Amoxicillin or Amoxicillin/ClavulanateWho this might be right forBacterial Infections Liaquat University of Medical & Health Sciences 121
Early research (Phase 1)Study completedNCT01548703What this trial is testingA Multiple Ascending Dose Study of BCI-838 in Healthy VolunteersWho this might be right forHealthy BrainCells Inc. 30
Testing effectiveness (Phase 2)Ended earlyNCT04375527What this trial is testingBinimetinib and Nivolumab for the Treatment of Locally Advanced Unresectable or Metastatic BRAF V600 Wildtype MelanomaWho this might be right forClinical Stage III Cutaneous Melanoma AJCC V8Clinical Stage IV Cutaneous Melanoma AJCC V8Locally Advanced Cutaneous Melanoma+8 more Jonsson Comprehensive Cancer Center 3
Early research (Phase 1)Ended earlyNCT00058773What this trial is testingGiving Gene Marked EBV Specific T-Cells to Patients Receiving a BMT for Relapsed EBV-Positive Hodgkin DiseaseWho this might be right forHodgkin DiseaseNon-Hodgkins Lymphoma Baylor College of Medicine 5
Testing effectiveness (Phase 2)Ended earlyNCT01093183What this trial is testingLenalidomide and Cyclophosphamide in Treating Patients With Previously Treated Hormone-Refractory Prostate CancerWho this might be right forAdenocarcinoma of the ProstateHormone-resistant Prostate CancerRecurrent Prostate Cancer University of Nebraska 25
Testing effectiveness (Phase 2)UnknownNCT04247256What this trial is testingTrial of SCO-101 in Combination With FOLFIRI for Patients With Metastatic Colorectal Cancer (mCRC) With Acquired Resistance to FOLFIRIWho this might be right forMetastatic Colorectal Cancer Scandion Oncology A/S 35
Not applicableEnded earlyNCT04370522What this trial is testingCharacterization of Innate Immune System in Patients With Luminal Advanced Breast CancerWho this might be right forMetastatic Breast Cancer Spanish Breast Cancer Research Group 32
Not applicableLooking for participantsNCT06600802What this trial is testingIntrinsic Validity of Molecular Marker(s) Detection on Tissular Tumoral DNA to Predict the Efficacy of 177Lutetium-PSMA-617 (Lu-PSMA) Treatment for Castration-resistant Metastatic Prostate CancerWho this might be right forCastration-resistant Metastatic Prostate CancerTreated by 177Lutetium-PSMA-617 (Lu-PSMA) Centre Jean Perrin 120
Post-approval studies (Phase 4)Looking for participantsNCT05979545What this trial is testingEaRly impAct theraPy With Ceftazidime-avibactam Via rapID DiagnosticsWho this might be right forBlood Stream InfectionsVentilator Associated PneumoniaHealthcare Associated Infection+2 more National University of Singapore 1,900
Not applicableStudy completedNCT03223727What this trial is testingTreatment Outcomes in a Non-study Population of Symptomatic mCRPC Patients Treated With Radium-223Who this might be right forProstate Cancer MetastaticBone Metastases The Netherlands Cancer Institute 100
Early research (Phase 1)Looking for participantsNCT07316686What this trial is testingPhase I Study of Docetaxel and 177-Lutetium-PSMA-I&T in First-Line Treatment for Patients With Metastatic Castration-Resistant Prostate AdenocarcinomaWho this might be right forProstate Cancer (Adenocarcinoma) Instituto do Cancer do Estado de São Paulo 18
Not applicableWithdrawnNCT05089786What this trial is testingEcho-Focusing in Patients With Treatment-Resistant Neurologic and Psychiatric Indications (EF001)Who this might be right forEssential TremorNeurology InSightec
Post-approval studies (Phase 4)Study completedNCT02058173What this trial is testing"Pharmacoepidemiological Evaluation of Autophagy Inhibition in Treatment of HCV Patients Resistant to Standard Therapy. Pilot Study"Who this might be right forHepatitis C Virus Shiraz University of Medical Sciences 10
Not applicableStudy completedNCT00887094What this trial is testingAerobic Training, Aerobic-resistance Training and Glucose Profile (CGMS) in Type 2 DiabetesWho this might be right forDiabetes Mellitus, Type 2TreatmentExercise Hospital de Clinicas de Porto Alegre 14
Large-scale testing (Phase 3)Looking for participantsNCT07668856What this trial is testingCannabidiol as add-on Therapy for Children With Refractory Epilepsy (CBD-uN1que), a High-quality Individualized Approach: a Series of N-of-1 TrialsWho this might be right forRefractory Epilepsy in ChildrenRefractory EpilepsyEpilepsy UMC Utrecht 50
Not applicableNot Yet RecruitingNCT06694129What this trial is testingReal-world Observational Study of Targeted Therapy in Patients With Advanced ROS1-positive NSCLCWho this might be right forNon-Small Cell Lung CancerROS1 Gene RearrangementResistance+1 more National Cancer Center, China 40
Testing effectiveness (Phase 2)Study completedNCT01754337What this trial is testingClosed-loop Control of Glucose Levels (Artificial Pancreas) for 24 Hours in Adults and Adolescents With Type 1 DiabetesWho this might be right forType 1 Diabetes Institut de Recherches Cliniques de Montreal 30